Regenovue Non-Lidocaine: A Professional Comparison Guide

Regenovue Non-Lidocaine is a monophasic hyaluronic acid dermal filler manufactured by NeoGenesis Co., Ltd. in South Korea. It is formulated without lidocaine, making it a suitable option for patients with sensitivities or for practitioners who prefer to manage comfort independently. This product is typically considered for addressing superficial to moderate lines and mild volume augmentation, providing practitioners with a versatile tool for various aesthetic objectives. Its precise rheological properties are designed to facilitate smooth injection and integration into tissues.

When evaluating options for professional use, several other Korean-made HA fillers are often compared. For this analysis, we consider Elasty Plus and UNIONFILL, both recognized brands within the aesthetic injectable market. These products also offer distinct formulations and intended applications, providing clinics with a range of choices depending on specific treatment needs and patient profiles. Understanding the nuances between these lines assists in optimizing product inventory for your practice.

To aid in procurement decisions, this table presents a direct comparison of key features for Regenovue Non-Lidocaine alongside the Elasty Plus range and UNIONFILL. This overview helps professionals identify which products align best with their clinic's service offerings and patient base.

For a broader view of available options, explore our comprehensive Hyaluronic acid dermal filler catalog.

All three discussed brands—Regenovue, Elasty Plus, and UNIONFILL—are monophasic hyaluronic acid fillers. The specific cross-linking technology and HA concentration determine their rheological properties, such as viscosity, cohesivity, and elasticity. Regenovue Non-Lidocaine typically features a formulation suited for smoother injections for finer applications. In contrast, the Elasty Plus 1CC range, for instance, includes products designed for varying depths, from fine lines to robust volume restoration, indicating a spectrum of viscosities and elasticities within its product family. Similarly, UNIONFILL offers different densities to address diverse aesthetic requirements, including contouring and profound volume restoration.

A notable difference is the presence or absence of lidocaine. Regenovue Non-Lidocaine, as its name indicates, is free of the anesthetic. This provides practitioners with full control over patient comfort strategies and is critical for patients with lidocaine allergies or sensitivities. Many products within the Elasty Plus and UNIONFILL lines, however, offer formulations containing lidocaine. This can streamline the procedure for some clinics by providing integrated pain management. Professional consideration of these options should align with clinic protocols and patient preferences, as highlighted in related discussions on product choices like Dermalax Deep Plus: Professional Comparison with HA Filler A.

When deciding which HA fillers to stock, professionals evaluate several factors beyond product characteristics. Wholesale pricing structures, volume tiers, and reliable supply chains are paramount. Regenovue Non-Lidocaine, with its illustrative wholesale price of $75.8/unit, demonstrates common volume-based tiering. Similar pricing models apply across many product lines, including alternatives like LEXYAL. Clinics should consider their anticipated usage volume and consult detailed pricing for optimized inventory management. Ensuring a consistent supply of original, traceable products is fundamental to maintaining professional standards.